For decades, sleeping sickness, a deadly neglected disease that affects the most isolated and underserved communities in rural Africa, has claimed countless lives and placed a heavy burden on those with the least access to care.
Until now, patients with advanced disease have had little choice but to endure long, gruelling hospital stays, hooked up to IV treatments with harsh side effects. But now, a quiet revolution is underway.
